MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,589,910 | +342.7% | 82,413 | +267.2% | 0.00% | – |
Q2 2023 | $810,938 | +9.4% | 22,445 | +12.5% | 0.00% | – |
Q1 2023 | $741,481 | -1.5% | 19,943 | +20.0% | 0.00% | – |
Q4 2022 | $752,962 | -29.0% | 16,618 | +9.3% | 0.00% | -100.0% |
Q3 2022 | $1,061,000 | +11.9% | 15,199 | +7.6% | 0.00% | 0.0% |
Q2 2022 | $948,000 | +43.0% | 14,124 | +75.1% | 0.00% | – |
Q1 2022 | $663,000 | +208.4% | 8,068 | +565.1% | 0.00% | – |
Q3 2021 | $215,000 | -21.2% | 1,213 | -23.9% | 0.00% | – |
Q1 2021 | $273,000 | -9.6% | 1,593 | +15.9% | 0.00% | – |
Q4 2020 | $302,000 | -5.6% | 1,374 | -28.7% | 0.00% | – |
Q3 2020 | $320,000 | – | 1,926 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |